The Rheumatology Podcast

Dr. Latika Gupta and Dr. Julie Paik (Johns Hopkins, Baltimore, USA) discuss the treatment of calcinosis in refractory dermatomyositis with tofacitinib monotherapy.

Dr. Latika Gupta and Dr. Julie Paik (Johns Hopkins, Baltimore, USA) discuss the treatment of calcinosis in refractory dermatomyositis with tofacitinib monotherapy.

Dr. Sheilla Achieng talks to Dr. Sara Booth (Emeritus consultant, University of Cambridge, UK) about the impact of NHS employment practice on people with SLE.

Dr. Sheilla Achieng talks to Dr. Sara Booth (Emeritus consultant, University of Cambridge, UK) about the impact of NHS employment practice on people with SLE.

Dr Marwan Bukhari and Dr Chris Rooney (University of Leeds) discuss the Editor’s Choice for July. This study examines the gut microbiome of anti-CCP positive individuals at risk of RA with a long term view to identifying new targets for preventative

Dr Marwan Bukhari and Dr Chris Rooney (University of Leeds) discuss the Editor’s Choice for July. This study examines the gut microbiome of anti-CCP positive individuals at risk of RA with a long term view to identifying new targets for preventative

Dr Sheilla Achieng and Dr Gouri Koduri (Southend, UK) discuss patient perceptions of comorbidities in inflammatory arthritis.

Dr Sheilla Achieng and Dr Gouri Koduri (Southend, UK) discuss patient perceptions of comorbidities in inflammatory arthritis.

Dr Pankti Mehta asks Dr Mark McClure (Cambridge, UK) about his recent study, which aimed to develop relapse and infection prediction models for long-term rituximab therapy in ANCA-associated vasculitis.

Dr Marwan Bukhari talks to Prof. David Jayne (Cambridge, UK), Dr Rona Smith (Cambridge, UK) and Dr Allyson Egan (Cambridge, UK) about the recent European Vasculitis Society (EUVAS) supplement.